Abstract
A potent and selective inhibitor of KCNQ2, (S)-5 (ML252, IC 50 = 69 nM), was discovered after a high-throughput screen of the MLPCN library was performed. SAR studies revealed a small structural change (ethyl group to hydrogen) caused a functional shift from antagonist to agonist activity (37, EC 50 = 170 nM), suggesting an interaction at a critical site for controlling gating of KCNQ2 channels.
Original language | English (US) |
---|---|
Pages (from-to) | 6975-6979 |
Number of pages | 5 |
Journal | Journal of medicinal chemistry |
Volume | 55 |
Issue number | 15 |
DOIs | |
State | Published - Aug 9 2012 |
Externally published | Yes |
ASJC Scopus subject areas
- Molecular Medicine
- Drug Discovery